Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women
| Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
|---|---|
| Data(s) |
19/10/2012
19/10/2012
2010
|
| Resumo |
Background: The purpose of this study was to evaluate the effect of long-term use of oral contraceptives (DC) containing 0.20 mg of ethinylestradiol (EE) combined with 0.15 mg of gestodene (GEST) on the peak aerobic capacity and at the anaerobic threshold (AT) level in active and sedentary young women. Study Design: Eighty-eight women (23 +/- 2.1 years old) were divided into four groups active-OC (G1), active-NOC (G2), sedentary-OC (G3) and sedentary-NOC (G4) and were submitted to a continuous ergospirometric incremental test on a cycloergometer with 20 to 25 W min(-1) increments. Data were analyzed by two-way ANOVA with Tukey post hoc test. Level of significance was set at 5%. Results: The OC use effect for the variables relative and absolute oxygen uptake VO(2) mL kg(-1) min(-1); VO(2), L min(-1), respectively), carbon dioxide output (VCO(2), L min(-1)), ventilation (VE, L min(-1)), heart rate (HR, bpm), respiratory exchange ratio (RER) and power output (W) data, as well as the interaction between OC use and exercise effect on the peak of test and at the AT level did not differ significantly between the active groups (G1 and G2) and the sedentary groups (G3 and G4). As to the exercise effect, for all variables studied, it was noted that the active groups presented higher values for the variables VO(2), VCO(2), VE and power output (p<.05) than the sedentary groups. The RER and HR were similar (p>.05) at the peak and at the AT level between G1 vs. G3 and G2 vs. G4. Conclusions: Long-term use of OC containing EE 0.20 mg plus GEST 0.15 mg does not affect aerobic capacity at the peak and at the AT level of exercise tests. (C) 2010 Elsevier Inc. All rights reserved. CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico[370448/2007-3] FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[2006/56788-1] |
| Identificador |
CONTRACEPTION, v.81, n.4, p.309-315, 2010 0010-7824 http://producao.usp.br/handle/BDPI/24523 10.1016/j.contraception.2009.11.005 |
| Idioma(s) |
eng |
| Publicador |
ELSEVIER SCIENCE INC |
| Relação |
Contraception |
| Direitos |
restrictedAccess Copyright ELSEVIER SCIENCE INC |
| Palavras-Chave | #Oral contraceptive #Ethinylestradiol #Gestodene #Aerobic capacity #MENSTRUAL-CYCLE #CHLORMADINONE ACETATE #EXERCISE PERFORMANCE #METABOLISM #RESPONSES #DESOGESTREL #TRIAL #PHASE #USERS #Obstetrics & Gynecology |
| Tipo |
article original article publishedVersion |